Alvotech (ALVO) Interest Coverage Ratio (2021 - 2026)
Alvotech's (ALVO) quarterly Interest Coverage Ratio came in at 1.79 in Q2 2026, up 649.91% on a YoY basis from 0.24 in Q2 2025, and up 854.94% quarter-over-quarter from 0.24 in Q1 2026.
Powered by 
Analysis
Alvotech (ALVO) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Interest Coverage Ratio for 6 consecutive years, with 1.79 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio rose 649.91% year-over-year to 1.79; the trailing twelve-month figure through Jun 2026 stood at 0.92 (up 336.3% YoY), and the FY2025 full-year result was 0.52, down 155.33% from the prior year.
- Interest Coverage Ratio rose to 1.79 in Q2 2026 per ALVO's latest filing, from 0.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 6.24 in Q3 2024 and bottomed at 2.33 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 1.32 across 5 years, with a median of 1.33 in 2023.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 986.1% in 2025, then surged 649.91% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 1.84 in 2022, then dropped by 27.76% to 1.33 in 2023, then sank by 52.37% to 0.63 in 2024, then plunged by 262.21% to 1.03 in 2025, then jumped by 274.38% to 1.79 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.79, 0.24, and 1.03 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.58 Bn | 38.93 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.36 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.35 Bn | 507.63 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.96 Mn | 705.83 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 401.41 Mn | 360.16 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 |
| Mar 31, 2026 | -0.24 |
| Dec 31, 2025 | -1.03 |
| Sep 30, 2025 | 1.83 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | -2.33 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 6.24 |
| Jun 30, 2024 | 1.54 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | 1.33 |
| Aug 31, 2023 | 2.94 |
| Jun 30, 2023 | 1.04 |
| Mar 20, 2023 | 1.33 |
| Dec 31, 2022 | 1.84 |
| Aug 31, 2022 | 3.88 |
| Jun 30, 2022 | 0.59 |
| Mar 20, 2022 | 1.84 |
| Dec 31, 2021 | 2.01 |
| Sep 30, 2021 | 2.24 |